Stocks and Investing
Stocks and Investing
Wed, May 1, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, April 30, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Ed Arce Reiterated (TERN) at Hold and Held Target at $5.5 on, Apr 30th, 2024
Ed Arce of HC Wainwright & Co., Reiterated "Terns Pharmaceuticals, Inc." (TERN) at Hold and Held Target at $5.5 on, Apr 30th, 2024.
Ed has made no other calls on TERN in the last 4 months.
There are 2 other peers that have a rating on TERN. Out of the 2 peers that are also analyzing TERN, 0 agree with Ed's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Ed
- Eliana Merle of "UBS" Maintained at Strong Buy with Decreased Target to $18 on, Wednesday, March 27th, 2024
- Etzer Darout of "BMO Capital" Maintained at Buy with Increased Target to $19 on, Friday, March 15th, 2024
Contributing Sources